ID   BASI_HUMAN              Reviewed;         385 AA.
AC   P35613; A6NJW1; D3YLG5; Q7Z796; Q8IZL7;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   31-AUG-2004, sequence version 2.
DT   10-MAY-2017, entry version 189.
DE   RecName: Full=Basigin;
DE   AltName: Full=5F7;
DE   AltName: Full=Collagenase stimulatory factor;
DE   AltName: Full=Extracellular matrix metalloproteinase inducer;
DE            Short=EMMPRIN;
DE   AltName: Full=Leukocyte activation antigen M6;
DE   AltName: Full=OK blood group antigen;
DE   AltName: Full=Tumor cell-derived collagenase stimulatory factor;
DE            Short=TCSF;
DE   AltName: CD_antigen=CD147;
DE   Flags: Precursor;
GN   Name=BSG; ORFNames=UNQ6505/PRO21383;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1634773;
RA   Kasinrerk W., Fiebiger E., Stefanova I., Baumruker T., Knapp W.,
RA   Stockinger H.;
RT   "Human leukocyte activation antigen M6, a member of the Ig
RT   superfamily, is the species homologue of rat OX-47, mouse basigin, and
RT   chicken HT7 molecule.";
RL   J. Immunol. 149:847-854(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RX   PubMed=1783610;
RA   Miyauchi T., Masuzawa Y., Muramatsu T.;
RT   "The basigin group of the immunoglobulin superfamily: complete
RT   conservation of a segment in and around transmembrane domains of human
RT   and mouse basigin and chicken HT7 antigen.";
RL   J. Biochem. 110:770-774(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=7812975;
RA   Biswas C., Zhang Y., Decastro R., Guo H., Nakamura T., Kataoka H.,
RA   Nabeshima K.;
RT   "The human tumor cell-derived collagenase stimulatory factor (renamed
RT   EMMPRIN) is a member of the immunoglobulin superfamily.";
RL   Cancer Res. 55:434-439(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RA   Wakasugi H., Scamps C., Yang G., Vancong N., Bernheim A., Tursz T.,
RA   Harada N.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RA   Decastro R., Zhang Y., Kataoka H., Coon J., Biswas C.;
RL   Submitted (MAR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2).
RX   PubMed=9767135; DOI=10.1016/S0378-1119(98)00400-4;
RA   Guo H., Majmudar G., Jensen T.C., Biswas C., Toole B.P., Gordon M.K.;
RT   "Characterization of the gene for human EMMPRIN, a tumor cell surface
RT   inducer of matrix metalloproteinases.";
RL   Gene 220:99-108(1998).
RN   [7]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RA   Sato T., Takita M., Noguchi Y., Hirata M., Sakai T., Ito A.;
RT   "Regulation of EMMPRIN/CD147 expression and its function of
RT   controlling matrix metalloproteinases production and cell-surface
RT   localization in co-culture of human uterine cervical carcinoma SKG-II
RT   cells and human uterine cervical fibroblasts.";
RL   Submitted (OCT-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 2).
RA   Kim D., Kanai Y., Choi H., Shin H., Kim J., Teraoka H., Shigeta Y.,
RA   Chairoungdua A., Babu E., Anzai N., Iribe Y., Endou H.;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RC   TISSUE=Retina;
RX   PubMed=12939332; DOI=10.1167/iovs.02-0995;
RA   Ochrietor J.D., Moroz T.P., van Ekeris L., Clamp M.F., Jefferson S.C.,
RA   deCarvalho A.C., Fadool J.M., Wistow G., Muramatsu T., Linser P.J.;
RT   "Retina-specific expression of 5A11/Basigin-2, a member of the
RT   immunoglobulin gene superfamily.";
RL   Invest. Ophthalmol. Vis. Sci. 44:4086-4096(2003).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4), SUBUNIT, SUBCELLULAR
RP   LOCATION, AND ALTERNATIVE PROMOTER USAGE.
RX   PubMed=21536654; DOI=10.1128/MCB.05160-11;
RA   Liao C.G., Kong L.M., Song F., Xing J.L., Wang L.X., Sun Z.J.,
RA   Tang H., Yao H., Zhang Y., Wang L., Wang Y., Yang X.M., Li Y.,
RA   Chen Z.N.;
RT   "Characterization of basigin isoforms and the inhibitory function of
RT   basigin-3 in human hepatocellular carcinoma proliferation and
RT   invasion.";
RL   Mol. Cell. Biol. 31:2591-2604(2011).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   PROTEIN SEQUENCE OF 22-36 (ISOFORM 1).
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [17]
RP   PARTIAL PROTEIN SEQUENCE, AND CHARACTERIZATION.
RX   PubMed=1846736; DOI=10.1016/0003-9861(91)90332-D;
RA   Nabeshima K., Lane W.S., Biswas C.;
RT   "Partial sequencing and characterization of the tumor cell-derived
RT   collagenase stimulatory factor.";
RL   Arch. Biochem. Biophys. 285:90-96(1991).
RN   [18]
RP   REVIEW.
RX   PubMed=12792908;
RA   Muramatsu T., Miyauchi T.;
RT   "Basigin (CD147): a multifunctional transmembrane protein involved in
RT   reproduction, neural function, inflammation and tumor invasion.";
RL   Histol. Histopathol. 18:981-987(2003).
RN   [19]
RP   GLYCOSYLATION AT ASN-160 AND ASN-268.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [20]
RP   INTERACTION WITH PPIL2, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   PRO-327.
RX   PubMed=15946952; DOI=10.1074/jbc.M503770200;
RA   Pushkarsky T., Yurchenko V., Vanpouille C., Brichacek B., Vaisman I.,
RA   Hatakeyama S., Nakayama K.I., Sherry B., Bukrinsky M.I.;
RT   "Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin
RT   60.";
RL   J. Biol. Chem. 280:27866-27871(2005).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [22]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SLC16A1.
RX   PubMed=17127621; DOI=10.1080/09687860600841967;
RA   Manoharan C., Wilson M.C., Sessions R.B., Halestrap A.P.;
RT   "The role of charged residues in the transmembrane helices of
RT   monocarboxylate transporter 1 and its ancillary protein basigin in
RT   determining plasma membrane expression and catalytic activity.";
RL   Mol. Membr. Biol. 23:486-498(2006).
RN   [24]
RP   INTERACTION WITH AJAP1.
RX   PubMed=17267690; DOI=10.1091/mbc.E06-07-0637;
RA   Schreiner A., Ruonala M., Jakob V., Suthaus J., Boles E., Wouters F.,
RA   Starzinski-Powitz A.;
RT   "junction protein shrew-1 influences cell invasion and interacts with
RT   invasion-promoting protein CD147.";
RL   Mol. Biol. Cell 18:1272-1281(2007).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-160 AND ASN-268.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [27]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-160 AND ASN-268.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362 AND SER-368, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [33]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 140-321, SUBUNIT, AND
RP   DISULFIDE BONDS.
RX   PubMed=18430721; DOI=10.1074/jbc.M802694200;
RA   Yu X.-L., Hu T., Du J.-M., Ding J.-P., Yang X.-M., Zhang J., Yang B.,
RA   Shen X., Zhang Z., Zhong W.-D., Wen N., Jiang H., Zhu P., Chen Z.-N.;
RT   "Crystal structure of HAb18G/CD147: implications for immunoglobulin
RT   superfamily homophilic adhesion.";
RL   J. Biol. Chem. 283:18056-18065(2008).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 13-219, IDENTIFICATION BY
RP   MASS SPECTROMETRY, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=19768682; DOI=10.1002/prot.22577;
RA   Luo J., Teplyakov A., Obmolova G., Malia T., Wu S.-J., Beil E.,
RA   Baker A., Swencki-Underwood B., Zhao Y., Sprenkle J., Dixon K.,
RA   Sweet R., Gilliland G.L.;
RT   "Structure of the EMMPRIN N-terminal domain 1: dimerization via beta-
RT   strand swapping.";
RL   Proteins 77:1009-1014(2009).
RN   [36]
RP   VARIANT LYS-208.
RX   PubMed=9130641; DOI=10.1002/eji.1830270414;
RA   Spring F.A., Holmes C.H., Simpson K.L., Mawby W.J., Mattes M.J.,
RA   Okubo Y., Parsons S.F.;
RT   "The Ok(a) blood group antigen is a marker for the M6 leukocyte
RT   activation antigen, the human homolog of OX-47 antigen, basigin and
RT   neurothelin, an immunoglobulin superfamily molecule that is widely
RT   expressed in human cells and tissues.";
RL   Eur. J. Immunol. 27:891-897(1997).
CC   -!- FUNCTION: Plays an important role in targeting the monocarboxylate
CC       transporters SLC16A1, SLC16A3 and SLC16A8 to the plasma membrane.
CC       Plays pivotal roles in spermatogenesis, embryo implantation,
CC       neural network formation and tumor progression. Stimulates
CC       adjacent fibroblasts to produce matrix metalloproteinases (MMPS).
CC       Seems to be a receptor for oligomannosidic glycans. In vitro,
CC       promotes outgrowth of astrocytic processes.
CC       {ECO:0000269|PubMed:17127621}.
CC   -!- SUBUNIT: Forms homooligomers in a cis-dependent manner on the
CC       plasma membrane. Forms heterooligomers of isoform 2 and isoform 3.
CC       Forms a complex with MMP1 at the tumor cell surface. Interacts
CC       with ATP1B2, MAG and L1CAM (By similarity). Interacts with AJAP1.
CC       Interacts with SLC16A1, SLC16A7 and SLC1A3; probably a BSG dimer
CC       is associated with a monocarboxylate transporter dimer. Interacts
CC       with PPIL2; regulates BSG transport to the cell membrane.
CC       {ECO:0000250|UniProtKB:P18572, ECO:0000250|UniProtKB:P26453,
CC       ECO:0000269|PubMed:15946952, ECO:0000269|PubMed:17127621,
CC       ECO:0000269|PubMed:17267690, ECO:0000269|PubMed:18430721,
CC       ECO:0000269|PubMed:19768682, ECO:0000269|PubMed:21536654}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15946952,
CC       ECO:0000269|PubMed:17127621, ECO:0000269|PubMed:21536654}; Single-
CC       pass type I membrane protein {ECO:0000303|PubMed:15946952}.
CC       Melanosome {ECO:0000269|PubMed:17081065}. Note=Identified by mass
CC       spectrometry in melanosome fractions from stage I to stage IV. In
CC       spermatozoa, localized on the principal piece of caput and in the
CC       middle piece during transit in the corpus and cauda epididymides
CC       (By similarity). {ECO:0000250|UniProtKB:P18572,
CC       ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long, Basigin-2;
CC         IsoId=P35613-1; Sequence=Displayed;
CC       Name=2; Synonyms=Basigin-1;
CC         IsoId=P35613-2; Sequence=VSP_011501;
CC       Name=3; Synonyms=Basigin-3;
CC         IsoId=P35613-3; Sequence=VSP_043225;
CC         Note=Produced by alternative promoter usage. N-glycosylated.;
CC       Name=4; Synonyms=Basigin-4;
CC         IsoId=P35613-4; Sequence=VSP_043226, VSP_043227;
CC         Note=Produced by alternative promoter usage. N-glycosylated.;
CC   -!- TISSUE SPECIFICITY: Present only in vascular endothelium in non-
CC       neoplastic regions of the brain, whereas it is present in tumor
CC       cells but not in proliferating blood vessels in malignant gliomas.
CC   -!- INDUCTION: Enriched on the surface of tumor cells. Up-regulated in
CC       gliomas. Its expression levels correlate with malignant potential
CC       of the tumor.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:12754519,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19349973}.
CC   -!- WEB RESOURCE: Name=dbRBC/BGMUT; Note=Blood group antigen gene
CC       mutation database;
CC       URL="https://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=ok";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/bsg/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X64364; CAA45716.1; -; mRNA.
DR   EMBL; D45131; BAA08109.1; -; mRNA.
DR   EMBL; L10240; AAA68936.1; -; mRNA.
DR   EMBL; M87879; AAA91084.1; -; mRNA.
DR   EMBL; L20471; AAB41120.1; -; mRNA.
DR   EMBL; AF042854; AAD10704.1; -; Genomic_DNA.
DR   EMBL; AF042848; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AF042849; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AF042850; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AF042851; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AF042852; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AF042853; AAD10704.1; JOINED; Genomic_DNA.
DR   EMBL; AB072923; BAB88938.1; -; mRNA.
DR   EMBL; AB085790; BAC76828.1; -; mRNA.
DR   EMBL; AF548371; AAN40694.1; -; mRNA.
DR   EMBL; GU557064; ADD31881.1; -; mRNA.
DR   EMBL; GU557065; ADD31882.1; -; mRNA.
DR   EMBL; AY358113; AAQ88480.1; -; mRNA.
DR   EMBL; AY942196; AAX20110.1; -; Genomic_DNA.
DR   EMBL; AC005559; AAC33279.1; -; Genomic_DNA.
DR   EMBL; CH471242; EAW61181.1; -; Genomic_DNA.
DR   EMBL; CH471242; EAW61185.1; -; Genomic_DNA.
DR   EMBL; BC009040; AAH09040.1; -; mRNA.
DR   CCDS; CCDS12032.1; -. [P35613-4]
DR   CCDS; CCDS12033.1; -. [P35613-1]
DR   CCDS; CCDS12034.1; -. [P35613-2]
DR   CCDS; CCDS58635.1; -. [P35613-3]
DR   PIR; A46506; A46506.
DR   RefSeq; NP_001309172.1; NM_001322243.1. [P35613-2]
DR   RefSeq; NP_001719.2; NM_001728.3. [P35613-1]
DR   RefSeq; NP_940991.1; NM_198589.2. [P35613-2]
DR   RefSeq; NP_940992.1; NM_198590.2. [P35613-3]
DR   RefSeq; NP_940993.1; NM_198591.2. [P35613-4]
DR   RefSeq; XP_016882662.1; XM_017027173.1. [P35613-1]
DR   UniGene; Hs.501293; -.
DR   PDB; 3B5H; X-ray; 2.80 A; A/B/C/D=140-321.
DR   PDB; 3I84; X-ray; 2.00 A; A/B=13-219.
DR   PDB; 3I85; X-ray; 2.50 A; A/B=13-219.
DR   PDB; 3QQN; X-ray; 2.31 A; A/B=23-138.
DR   PDB; 3QR2; X-ray; 2.30 A; A/B=23-138.
DR   PDB; 4U0Q; X-ray; 3.10 A; B/D=1-385.
DR   PDBsum; 3B5H; -.
DR   PDBsum; 3I84; -.
DR   PDBsum; 3I85; -.
DR   PDBsum; 3QQN; -.
DR   PDBsum; 3QR2; -.
DR   PDBsum; 4U0Q; -.
DR   ProteinModelPortal; P35613; -.
DR   SMR; P35613; -.
DR   BioGrid; 107147; 142.
DR   DIP; DIP-50310N; -.
DR   IntAct; P35613; 32.
DR   MINT; MINT-5004205; -.
DR   STRING; 9606.ENSP00000333769; -.
DR   ChEMBL; CHEMBL3580492; -.
DR   TCDB; 8.A.23.1.1; the basigin (basigin) family.
DR   iPTMnet; P35613; -.
DR   PhosphoSitePlus; P35613; -.
DR   SwissPalm; P35613; -.
DR   BioMuta; BSG; -.
DR   DMDM; 51704273; -.
DR   EPD; P35613; -.
DR   MaxQB; P35613; -.
DR   PaxDb; P35613; -.
DR   PeptideAtlas; P35613; -.
DR   PRIDE; P35613; -.
DR   TopDownProteomics; P35613-1; -. [P35613-1]
DR   TopDownProteomics; P35613-2; -. [P35613-2]
DR   TopDownProteomics; P35613-3; -. [P35613-3]
DR   DNASU; 682; -.
DR   Ensembl; ENST00000333511; ENSP00000333769; ENSG00000172270. [P35613-1]
DR   Ensembl; ENST00000346916; ENSP00000344707; ENSG00000172270. [P35613-4]
DR   Ensembl; ENST00000353555; ENSP00000343809; ENSG00000172270. [P35613-2]
DR   Ensembl; ENST00000545507; ENSP00000473664; ENSG00000172270. [P35613-3]
DR   GeneID; 682; -.
DR   KEGG; hsa:682; -.
DR   UCSC; uc002loy.5; human. [P35613-1]
DR   CTD; 682; -.
DR   DisGeNET; 682; -.
DR   GeneCards; BSG; -.
DR   HGNC; HGNC:1116; BSG.
DR   HPA; CAB002427; -.
DR   HPA; HPA036048; -.
DR   HPA; HPA074870; -.
DR   MIM; 109480; gene.
DR   MIM; 111380; phenotype.
DR   neXtProt; NX_P35613; -.
DR   OpenTargets; ENSG00000172270; -.
DR   PharmGKB; PA25433; -.
DR   eggNOG; ENOG410IJET; Eukaryota.
DR   eggNOG; ENOG4111V1Q; LUCA.
DR   GeneTree; ENSGT00390000010516; -.
DR   HOGENOM; HOG000263411; -.
DR   HOVERGEN; HBG008120; -.
DR   InParanoid; P35613; -.
DR   KO; K06535; -.
DR   OMA; QANVFVI; -.
DR   OrthoDB; EOG091G07LY; -.
DR   PhylomeDB; P35613; -.
DR   TreeFam; TF326759; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-210991; Basigin interactions.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-433692; Proton-coupled monocarboxylate transport.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   ChiTaRS; BSG; human.
DR   EvolutionaryTrace; P35613; -.
DR   GeneWiki; Basigin; -.
DR   GenomeRNAi; 682; -.
DR   PMAP-CutDB; P35613; -.
DR   PRO; PR:P35613; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000172270; -.
DR   CleanEx; HS_BSG; -.
DR   ExpressionAtlas; P35613; baseline and differential.
DR   Genevisible; P35613; HS.
DR   GO; GO:0002080; C:acrosomal membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0005537; F:mannose binding; IEA:UniProtKB-KW.
DR   GO; GO:0008028; F:monocarboxylic acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0046697; P:decidualization; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0042475; P:odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0072661; P:protein targeting to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0046689; P:response to mercury ion; IEA:Ensembl.
DR   GO; GO:0043434; P:response to peptide hormone; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR009151; Basigin.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR10075:SF17; PTHR10075:SF17; 1.
DR   SMART; SM00409; IG; 2.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative promoter usage; Alternative splicing;
KW   Blood group antigen; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Immunoglobulin domain; Lectin; Mannose-binding; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     21
FT   CHAIN        22    385       Basigin.
FT                                /FTId=PRO_0000014518.
FT   TOPO_DOM    138    323       Extracellular. {ECO:0000255}.
FT   TRANSMEM    324    344       Helical. {ECO:0000255}.
FT   TOPO_DOM    345    385       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      138    219       Ig-like C2-type.
FT   DOMAIN      221    315       Ig-like V-type.
FT   COMPBIAS    356    359       Poly-Asp.
FT   MOD_RES     362    362       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     368    368       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    160    160       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    268    268       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12754519,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    302    302       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    157    203       {ECO:0000244|PDB:3B5H,
FT                                ECO:0000244|PDB:3I84,
FT                                ECO:0000269|PubMed:18430721,
FT                                ECO:0000269|PubMed:19768682}.
FT   DISULFID    242    301       {ECO:0000244|PDB:3B5H,
FT                                ECO:0000269|PubMed:18430721}.
FT   VAR_SEQ       1    209       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:21536654}.
FT                                /FTId=VSP_043225.
FT   VAR_SEQ       1     11       MAAALFVLLGF -> MKQSDASPQER (in isoform
FT                                4). {ECO:0000303|PubMed:21536654}.
FT                                /FTId=VSP_043226.
FT   VAR_SEQ      12    191       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:21536654}.
FT                                /FTId=VSP_043227.
FT   VAR_SEQ      24    139       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1634773,
FT                                ECO:0000303|PubMed:7812975}.
FT                                /FTId=VSP_011501.
FT   VARIANT     208    208       E -> K (in Ok(A-); dbSNP:rs104894669).
FT                                {ECO:0000269|PubMed:9130641}.
FT                                /FTId=VAR_013574.
FT   VARIANT     269    269       G -> V (in dbSNP:rs1803203).
FT                                /FTId=VAR_011720.
FT   MUTAGEN     327    327       P->A: Loss of interaction with PPIL2.
FT                                {ECO:0000269|PubMed:15946952}.
FT   CONFLICT    328    328       F -> L (in Ref. 2; BAC76828).
FT                                {ECO:0000305}.
FT   STRAND       24     27       {ECO:0000244|PDB:3QR2}.
FT   STRAND       32     35       {ECO:0000244|PDB:3QR2}.
FT   STRAND       40     47       {ECO:0000244|PDB:3QR2}.
FT   STRAND       53     62       {ECO:0000244|PDB:3QR2}.
FT   HELIX        74     77       {ECO:0000244|PDB:3QR2}.
FT   STRAND       79     95       {ECO:0000244|PDB:3QR2}.
FT   HELIX       100    102       {ECO:0000244|PDB:3QR2}.
FT   STRAND      104    111       {ECO:0000244|PDB:3QR2}.
FT   STRAND      116    118       {ECO:0000244|PDB:3QR2}.
FT   STRAND      128    137       {ECO:0000244|PDB:3QR2}.
FT   STRAND      142    149       {ECO:0000244|PDB:3I84}.
FT   STRAND      152    159       {ECO:0000244|PDB:3I84}.
FT   STRAND      166    173       {ECO:0000244|PDB:3I84}.
FT   STRAND      176    181       {ECO:0000244|PDB:3I84}.
FT   STRAND      186    192       {ECO:0000244|PDB:3I84}.
FT   HELIX       194    196       {ECO:0000244|PDB:3I84}.
FT   STRAND      199    207       {ECO:0000244|PDB:3I84}.
FT   STRAND      210    217       {ECO:0000244|PDB:3I84}.
FT   STRAND      224    226       {ECO:0000244|PDB:3B5H}.
FT   STRAND      228    233       {ECO:0000244|PDB:3B5H}.
FT   STRAND      238    243       {ECO:0000244|PDB:3B5H}.
FT   STRAND      252    257       {ECO:0000244|PDB:3B5H}.
FT   STRAND      260    262       {ECO:0000244|PDB:3B5H}.
FT   STRAND      264    266       {ECO:0000244|PDB:4U0Q}.
FT   HELIX       270    272       {ECO:0000244|PDB:3B5H}.
FT   STRAND      274    279       {ECO:0000244|PDB:3B5H}.
FT   STRAND      282    287       {ECO:0000244|PDB:3B5H}.
FT   TURN        292    294       {ECO:0000244|PDB:3B5H}.
FT   STRAND      295    305       {ECO:0000244|PDB:3B5H}.
FT   STRAND      308    319       {ECO:0000244|PDB:3B5H}.
SQ   SEQUENCE   385 AA;  42200 MW;  D74C37455BF26685 CRC64;
     MAAALFVLLG FALLGTHGAS GAAGFVQAPL SQQRWVGGSV ELHCEAVGSP VPEIQWWFEG
     QGPNDTCSQL WDGARLDRVH IHATYHQHAA STISIDTLVE EDTGTYECRA SNDPDRNHLT
     RAPRVKWVRA QAVVLVLEPG TVFTTVEDLG SKILLTCSLN DSATEVTGHR WLKGGVVLKE
     DALPGQKTEF KVDSDDQWGE YSCVFLPEPM GTANIQLHGP PRVKAVKSSE HINEGETAML
     VCKSESVPPV TDWAWYKITD SEDKALMNGS ESRFFVSSSQ GRSELHIENL NMEADPGQYR
     CNGTSSKGSD QAIITLRVRS HLAALWPFLG IVAEVLVLVT IIFIYEKRRK PEDVLDDDDA
     GSAPLKSSGQ HQNDKGKNVR QRNSS
//
